3377 related articles for article (PubMed ID: 7597288)
21. Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes.
Halaban R; Fan B; Ahn J; Funasaka Y; Gitay-Goren H; Neufeld G
J Immunother (1991); 1992 Oct; 12(3):154-61. PubMed ID: 1445804
[TBL] [Abstract][Full Text] [Related]
22. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
[TBL] [Abstract][Full Text] [Related]
23. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
Krasagakis K; Garbe C; Schrier PI; Orfanos CE
Anticancer Res; 1994; 14(6B):2565-71. PubMed ID: 7872682
[TBL] [Abstract][Full Text] [Related]
24. Biology of tumor progression in human melanocytes.
Herlyn M; Clark WH; Rodeck U; Mancianti ML; Jambrosic J; Koprowski H
Lab Invest; 1987 May; 56(5):461-74. PubMed ID: 3553733
[TBL] [Abstract][Full Text] [Related]
25. Growth factor independence and growth regulatory pathways in human melanoma development.
Rodeck U
Cancer Metastasis Rev; 1993 Sep; 12(3-4):219-26. PubMed ID: 8281609
[TBL] [Abstract][Full Text] [Related]
26. Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
Lázár-Molnár E; Hegyesi H; Tóth S; Falus A
Cytokine; 2000 Jun; 12(6):547-54. PubMed ID: 10843728
[TBL] [Abstract][Full Text] [Related]
27. Modulation of fibronectin production in normal human melanocytes and malignant melanoma cells by interferon-gamma and tumor necrosis factor-alpha.
Varani J; Mitra RS; McClenic BJ; Fligiel SE; Inman DR; Dixit VM; Nickoloff BJ
Am J Pathol; 1989 Apr; 134(4):827-36. PubMed ID: 2495726
[TBL] [Abstract][Full Text] [Related]
28. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells.
Lefort K; Rouault JP; Tondereau L; Magaud JP; Doré JF
Oncogene; 2001 Nov; 20(50):7375-85. PubMed ID: 11704867
[TBL] [Abstract][Full Text] [Related]
29. Exposure of normal human melanocytes to a tumor promoting phorbol ester reverses growth suppression by transforming growth factor beta.
Stavroulaki M; Kardassis D; Chatzaki E; Sakellaris G; Lindschau C; Haller H; Tosca A; Krasagakis K
J Cell Physiol; 2008 Feb; 214(2):363-70. PubMed ID: 17654516
[TBL] [Abstract][Full Text] [Related]
30. Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines.
Colombo MP; Maccalli C; Mattei S; Melani C; Radrizzani M; Parmiani G
Melanoma Res; 1992 Sep; 2(3):181-9. PubMed ID: 1450672
[TBL] [Abstract][Full Text] [Related]
31. Adhesion, migration and communication in melanocytes and melanoma.
Haass NK; Smalley KS; Li L; Herlyn M
Pigment Cell Res; 2005 Jun; 18(3):150-9. PubMed ID: 15892711
[TBL] [Abstract][Full Text] [Related]
32. Proliferation and morphology of melanoma cells and benign human melanocytes under varying culture conditions.
Eberle J; Krasagakis K; Garbe C; Orfanos CE
Melanoma Res; 1993 Apr; 3(2):107-12. PubMed ID: 8518548
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte growth factor and melanoma: gene transfer studies in human melanocytes.
Hamoen KE; Borel Rinkes IH; Morgan JR
Melanoma Res; 2001 Apr; 11(2):89-97. PubMed ID: 11333132
[TBL] [Abstract][Full Text] [Related]
34. Human melanomas of fibroblast and epithelial morphology differ widely in their ability to synthesize retinyl esters.
Simmons DP; Andreola F; De Luca LM
Carcinogenesis; 2002 Nov; 23(11):1821-30. PubMed ID: 12419830
[TBL] [Abstract][Full Text] [Related]
35. Interferon-beta prevents the upregulation of interleukin-8 expression in human melanoma cells.
Singh RK; Gutman M; Llansa N; Fidler IJ
J Interferon Cytokine Res; 1996 Aug; 16(8):577-84. PubMed ID: 8877727
[TBL] [Abstract][Full Text] [Related]
36. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
37. Effect of ultraviolet-inducible cytokines on melanoma growth in vivo: stimulation of melanoma growth by interleukin-1 and -6.
Mckenzie RC; Park ES; Brown WR; Shivji GS; Sauder DN
Photodermatol Photoimmunol Photomed; 1994 Apr; 10(2):74-9. PubMed ID: 8043388
[TBL] [Abstract][Full Text] [Related]
38. Interferon-beta from melanoma cells suppresses the proliferations of melanoma cells in an autocrine manner.
Satomi H; Wang B; Fujisawa H; Otsuka F
Cytokine; 2002 Apr; 18(2):108-15. PubMed ID: 12096926
[TBL] [Abstract][Full Text] [Related]
39. Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins.
Mortarini R; Gismondi A; Maggioni A; Santoni A; Herlyn M; Anichini A
Cancer Res; 1995 Oct; 55(20):4702-10. PubMed ID: 7553652
[TBL] [Abstract][Full Text] [Related]
40. Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line.
Komyod W; Böhm M; Metze D; Heinrich PC; Behrmann I
Mol Cancer Res; 2007 Mar; 5(3):271-81. PubMed ID: 17374732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
